January 8, 2015
CHICAGO, IL – January 8, 2015 — SAMDI Tech is expanding its executive leadership team as it announces Emilio Córdova, Ph.D., MBA as its Chief Executive Officer. Córdova officially joins SAMDI Tech where he had previously served as Chief Business Officer in a consultancy role since 2011. Córdova has also been appointed to SAMDI Tech’s Board of Directors. He brings over 20 years of experience in the CRO space focused on all aspects of drug discovery research; most recently as Senior Vice President of Business Development at AIT Bioscience, a Bioanalytical Laboratory Contract Research Organization in Indianapolis, Indiana.
“I am excited to join SAMDI Tech as our technology is innovative to the Discovery field. The SAMDI technology delivers a high throughput quantitative solution to clients in Epigenetics and beyond.” said Córdova.
“Emilio Córdova brings to SAMDI Tech extensive experience in drug development and expertise in relationship building with innovative biotechnology and pharmaceutical companies.” said Dr. Milan Mrksich, Inventor of SAMDI and Founder of SAMDI Tech.
SAMDI is a unique label-free assay platform for measurement of complex biochemical activity.
Córdova holds a Bachelor of Arts from Drew University, a Master of Science and Doctor of Philosophy from the University of Miami (Fla.), and a post-doctoral fellowship with Professor George Whitesides at Harvard. He also earned a Master of Business Administration from Purdue University.
About SAMDI Tech, Inc
SAMDI Tech, Inc, headquartered in Chicago, IL is a contract research organization supporting discovery research. SAMDI’s pioneering technology combines surface chemistry and MALDI mass spectrometry in both 384 and 1536 format for rapid assay development, high-throughput screening, and peptide substrate discovery and supports both biotech and large pharmaceutical companies. Learn more about SAMDI Tech at www.samditech.com.
For More Information:
Senior Director of Business Development